Nilvadipine
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433905This classification denotes a calcium channel blocker with the molecular formula C19H19N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0214FUT37J, chemically known as 3,5-pyridinedicarboxylic acid, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-methyl 5-(1-methylethyl) ester but generally known as nilvadipine, which bears US NIH Compound Identifier 4494. European Medicines Agency schedules Nilvadipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09292MIG. The term NILVADIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules nilvadipine in its Anatomical Therapeutic Chemical (ATC) Classification. NILVADIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nilvadipine under HS 29333999 and SITC 51574. As of Q4 2014, NILVADIPINE remains the US FDA Preferred Term for this commodity. Nilvadipine bears US NLM identifiers UMLS ID C0132512 and NCI Concept Code C84019. SMILES: O(C(=O)C1=C(NC(=C(C1c1cc([N](=O)O)ccc1)C(=O)OC)C#N)C)C(C)C.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.